Bloomberg Podcasts
@bloombergpodcasts·503K subscribers·32.4K videos
Palantir Slides, Vertex Pharmaceuticals Surges, DoorDash Lower Despite Earnings Beat | Stock Movers
Posted
May 6, 2025
Views
123
Likes
1
Engagement
0.81%
May 6, 2025
123
1
0.81%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
7:43
2:50Now PlayingOn this episode of Stock Movers:
- Palantir (PLTR) shares slide by the most in nearly a year after its financial results and projections failed to live up to investors’ lofty expectations. The company described rising demand for artificial intelligence software as a “ravenous whirlwind” and bumped its 2025 revenue forecast on Monday to about $3.9 billion from about $3.75 billion.
- Vertex Pharmaceuticals (VRTX) shares fall after the company reported adjusted earnings per share for the first quarter that missed expectations. Analysts are mixed about the launch of the non-opioid pain medication Journavx and Alyftrek, a triple modulator for cystic fibrosis
- DoorDash (DASH) drops after announcing two multibillion-dollar acquisitions: London-based delivery company Deliveroo Plc for £2.9 billion and hospitality tech company SevenRooms Inc. for $1.2 billion. Alongside the deals, DoorDash also issued a strong orders outlook for the current quarter and posted better-than-expected gross order value for the first three months of the year in a statement on Tuesday.
See omnystudio.com/listener () for privacy information.
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street.
Check out more episodes of Stock Movers
Follow Bloomberg Podcasts on Twitter
Visit our other YouTube channels:
Bloomberg Television
Bloomberg Originals
For coverage on news, markets and more
#Stocks #Markets #Finance #Investing #Podcast #Bloomberg
Palantir Slides, Vertex Pharmaceuticals Surges, DoorDash Lower Despite Earnings Beat
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
